Instil Bio Poised for Growth Amid Biopharmaceutical Sector Activity and Strong Financial Position
H.C. Wainwright analyst Mitchell Kapoor reiterated a Buy rating on Instil Bio (TIL – Research Report) today and set a price target of ...
Instil Bio price target lowered to $110 from $120 at H.C. Wainwright
H.C. Wainwright lowered the firm’s price target on Instil Bio (TIL) to $110 from $120 and keeps a Buy rating on the shares post the Q3 ...